Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Long-Term Deferred Tax: 2020-2021

  • Journey Medical's Long-Term Deferred Tax was N/A to $8.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $8.4 million, marking a year-over-year change of. This contributed to the annual value of $1.5 million for FY2020, which is N/A change from last year.
  • As of Q3 2021, Journey Medical's Long-Term Deferred Tax stood at $8.4 million, which was up 475.03% from $1.5 million recorded in Q4 2020.
  • In the past 5 years, Journey Medical's Long-Term Deferred Tax ranged from a high of $8.4 million in Q3 2021 and a low of $1.5 million during Q4 2020.
  • Over the past 2 years, Journey Medical's median Long-Term Deferred Tax value was $4.9 million (recorded in 2020), while the average stood at $4.9 million.